clofibrate has been researched along with nad in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (53.57) | 18.7374 |
| 1990's | 9 (32.14) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 1 (3.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hashimoto, T; Imura, M; Miyazawa, S; Sakurai, T | 1 |
| De Duve, C; Lazarow, PB | 1 |
| Hassinen, IE; Jauhonen, VP; Savolainen, MJ | 1 |
| Rognstad, R | 1 |
| Eacho, PI; Foxworthy, PS; Hoover, DM; White, SL | 1 |
| Horie, S; Ogawa, S; Suga, T; Watanabe, T; Yamada, J | 1 |
| Haettinger, JR; Hutsell, TC; Mackerer, CR | 1 |
| Cederbaum, AI; Rubin, E | 1 |
| Kurup, CK; Panini, SR | 2 |
| Haettinger, JR; Mackerer, CR | 1 |
| McIntosh, DA; Topham, JC | 1 |
| Norseth, J; Thomassen, MS | 1 |
| Debeer, LJ; Mannaerts, GP | 1 |
| De Saint Blanquat, G; Lamboeuf, Y | 1 |
| Osmundsen, H | 1 |
| Antonenkov, VD; Panchenko, LF | 1 |
| Ishigami, M; Loo, Y; Sano, K; Sasaki, M; Shin, M; Umezawa, C; Yamashita, Y | 1 |
| Fujita, Y; Kimura, A; Mori, Y; Sano, K; Shin, M; Umezawa, C; Yoshida, K | 1 |
| Kondo, T; Marugami, M; Shibata, K; Umezawa, C | 1 |
| Iwamoto, N; Sano, K; Shin, M; Umezawa, C; Yamashita, M | 1 |
| Hashimoto, C; Nakakita, S; Sano, K; Shin, M; Umezawa, C | 1 |
| Asada, S; Mizumori, N; Sano, K; Shin, M; Umezawa, C | 1 |
| Sano, K; Shin, M; Umezawa, C | 1 |
| Hammock, BD; Morisseau, C; Newman, JW; Watanabe, T | 1 |
| Ohnishi, M; Sano, K; Shin, M; Umezawa, C | 1 |
| Egashira, Y; Sanada, H; Sato, M; Shin, M; Sugawara, R; Tanabe, A | 1 |
28 other study(ies) available for clofibrate and nad
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of ethyl p-chlorophenoxyisobutyrate on carbohydrate and fatty acid metabolism in rat liver.
Topics: Animals; Body Weight; Carbohydrate Metabolism; Cholesterol; Clofibrate; Cytoplasm; Diet; Fatty Acids; Fructosephosphates; Gluconeogenesis; Glutamate Dehydrogenase; Glycerophosphates; Hexosediphosphates; Hydroxybutyrate Dehydrogenase; L-Lactate Dehydrogenase; Liver; Male; Mitochondria, Liver; NAD; Organ Size; Rats; Triglycerides | 1975 |
A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.
Topics: Animals; Clofibrate; Coenzyme A; Liver; Microbodies; NAD; Organoids; Oxidation-Reduction; Palmitates; Rats | 1976 |
Effects of clofibrate on ethanol-induced modifications in liver and adipose tissue metabolism: role of hepatic redox state and hormonal mechanisms.
Topics: Adipose Tissue; Animals; Clofibrate; Cyclic AMP; Dihydroxyacetone Phosphate; Ethanol; Fatty Acids, Nonesterified; Glycerophosphates; Kinetics; Lactates; Liver; Male; NAD; Oxidation-Reduction; Pyruvates; Rats | 1977 |
Estimation of peroxisomal and mitochondrial fatty acid oxidation in rat hepatocytes using tritiated substrates.
Topics: Animals; Clofibrate; Fatty Acids; Liver; Microbodies; NAD; Oxidation-Reduction; Rats; Substrate Specificity; Tritium | 1991 |
Effect of ciprofibrate, bezafibrate, and LY171883 on peroxisomal beta-oxidation in cultured rat, dog, and rhesus monkey hepatocytes.
Topics: Acetophenones; Animals; Autacoids; Azoles; Bezafibrate; Cells, Cultured; Clofibrate; Clofibric Acid; Dexamethasone; Dogs; Dose-Response Relationship, Drug; Female; Fibric Acids; Glucagon; Hypolipidemic Agents; In Vitro Techniques; Liver; Male; Microbodies; Microscopy, Electron; NAD; Oxidation-Reduction; Rats; Tetrazoles; Tyrosine Transaminase | 1990 |
Participation of peroxisomes in the metabolism of xenobiotic acyl compounds: comparison between peroxisomal and mitochondrial beta-oxidation of omega-phenyl fatty acids in rat liver.
Topics: Acetyl Coenzyme A; Acyl-CoA Dehydrogenase, Long-Chain; Acyl-CoA Oxidase; Animals; Carnitine; Carnitine O-Palmitoyltransferase; Clofibrate; Coenzyme A Ligases; Fatty Acids; Ketone Bodies; Lauric Acids; Liver; Male; Microbodies; Mitochondria, Liver; NAD; Oxidation-Reduction; Oxidoreductases; Rats; Rats, Inbred Strains | 1987 |
Effects of clofibrate, in vitro, on mitochondrial respiration and oxidative phosphorylation.
Topics: Aniline Compounds; Animals; Ascorbic Acid; Butyrates; Clofibrate; Dinitrophenols; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Mitochondria, Liver; NAD; Oxidative Phosphorylation; Oxygen Consumption; Polarography; Rats; Succinates; Vibration | 1973 |
Effects of clofibrate on mitochondrial function.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Ascorbic Acid; Aspartic Acid; Calcium; Clofibrate; Energy Metabolism; Ethanol; Glycerophosphates; In Vitro Techniques; Ketoglutaric Acids; Malates; Membranes; Mitochondria, Liver; NAD; Oxidative Phosphorylation; Oxygen Consumption; Permeability; Phosphorus Radioisotopes; Rats; Succinates | 1974 |
Cooperativity in the inhibition of oxidative phosphorylation by chlorophenoxyisobutyrate.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Allosteric Regulation; Animals; Binding Sites; Clofibrate; Electron Transport; Energy Transfer; Kinetics; Mathematics; Mitochondria, Liver; NAD; Oxidation-Reduction; Oxidative Phosphorylation; Protein Binding; Rats; Uncoupling Agents | 1974 |
Mode of inhibition of mitochondrial energy transduction by chlorophenoxyisobutyrate.
Topics: Adenosine Triphosphatases; Animals; Clofibrate; Dinitrophenols; Electron Transport; Energy Transfer; Mitochondria, Liver; NAD; Oxidative Phosphorylation; Rats; Spectrophotometry; Subcellular Fractions; Succinates; Uncoupling Agents | 1974 |
Further studies concerning the effects of clofibrate on respiration and oxidative phosphorylation of rat liver mitochondria.
Topics: Adenosine Diphosphate; Animals; Blood Glucose; Butyrates; Calcium; Cholesterol; Clofibrate; Fatty Acids, Nonesterified; Freezing; Growth; Hydroxybutyrates; In Vitro Techniques; Liver; Male; Mitochondria, Liver; Mitochondrial Swelling; NAD; Nucleotides; Organ Size; Oxidation-Reduction; Oxidative Phosphorylation; Oxygen Consumption; Proteins; Rats; Rats, Inbred Strains; Stimulation, Chemical; Triglycerides | 1974 |
A comparison of mouse and rat liver enzymes and their response to treatment with various compounds.
Topics: Aminopyrine; Animals; Carbon Tetrachloride; Chlorpromazine; Clofibrate; Cytochromes; DDT; Germ-Free Life; Glucose-6-Phosphatase; Glucosephosphate Dehydrogenase; Griseofulvin; L-Lactate Dehydrogenase; Liver; Mice; NAD; NADP; Organ Size; Oxidoreductases; Phenobarbital; Phosphogluconate Dehydrogenase; Rats; Species Specificity | 1972 |
Stimulation of microperoxisomal beta-oxidation in rat heart by high-fat diets.
Topics: Animals; Clofibrate; Dietary Fats; Fatty Acids; Male; Microbodies; Myocardium; NAD; Organoids; Oxidation-Reduction; Palmitoyl Coenzyme A; Rats; Rats, Inbred Strains | 1983 |
Mitochondrial and peroxisomal beta-oxidation of fatty acids in rat liver.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Clofibrate; Coenzyme A; Fatty Acids; Kinetics; Liver; Microbodies; Mitochondria, Liver; NAD; Oleic Acid; Oleic Acids; Organoids; Oxidation-Reduction; Palmitic Acid; Palmitic Acids; Rats | 1982 |
Effects of cyanamide and clofibrate on the enzymes of ethanol oxydation and on ethanol consumption in the rat.
Topics: Alcohol Drinking; Alcohol Oxidoreductases; Aldehyde Oxidoreductases; Animals; Catalase; Clofibrate; Cyanamide; Cyanides; Drinking Behavior; Ethanol; Male; NAD; Rats | 1980 |
Factors which can influence beta-oxidation by peroxisomes isolated from livers of clofibrate treated rats. Some properties of peroxisomal fractions isolated in a self-generated Percoll gradient by vertical rotor centrifugation.
Topics: Animals; Centrifugation, Density Gradient; Chemical Phenomena; Chemistry; Clofibrate; Coenzyme A; Liver; Male; Microbodies; NAD; Organoids; Oxidation-Reduction; Rats; Rats, Inbred Strains | 1982 |
[Induction of the activity of malate dehydrogenase (decarboxylating) and lactate dehydrogenase in the liver by clofibrate].
Topics: Animals; Clofibrate; Cytosol; Dose-Response Relationship, Drug; Enzyme Induction; L-Lactate Dehydrogenase; Liver; Malate Dehydrogenase; Male; Microbodies; NAD; Rats; Rats, Inbred Strains; Time Factors | 1981 |
Effect of feeding clofibrate-containing diet on the hepatic NAD+ level in rats.
Topics: Animals; Clofibrate; Diet; Diethylhexyl Phthalate; Fenofibrate; Hypolipidemic Agents; Liver; Male; Microbodies; NAD; Rats; Rats, Sprague-Dawley | 1995 |
NAD+ biosynthesis and metabolic fluxes of tryptophan in hepatocytes isolated from rats fed a clofibrate-containing diet.
Topics: Animals; Cells, Cultured; Clofibrate; Diet; Liver; Male; NAD; Niacin; Pentosyltransferases; Rats; Rats, Sprague-Dawley; Tryptophan | 1996 |
Increased conversion ratio of tryptophan to niacin by the administration of clofibrate, a hypolipidemic drug, to rats.
Topics: Animals; Clofibrate; Hypolipidemic Agents; Liver; Male; NAD; Niacin; Niacinamide; Rats; Rats, Wistar; Tryptophan; Weaning; Weight Gain | 1996 |
Pyridine nucleotide levels in liver of rats fed clofibrate- or pyrazinamide-containing diets.
Topics: Animals; Clofibrate; Diet; Female; Hypolipidemic Agents; Liver; Male; NAD; NADP; Pyrazinamide; Rats; Rats, Sprague-Dawley | 1998 |
NAD+ biosynthesis from tryptophan in the presence of nicotinic acid or vice versa by rat hepatocytes--effect of clofibrate-feeding.
Topics: Animals; Biological Transport; Clofibrate; Glutarates; Hydrolases; Liver; Male; Microbodies; NAD; Niacin; Rats; Rats, Sprague-Dawley; Tryptophan | 1998 |
Effect of thioridazine or chlorpromazine on increased hepatic NAD+ level in rats fed clofibrate, a hypolipidaemic drug.
Topics: Animals; Antipsychotic Agents; Chlorpromazine; Clofibrate; Hypolipidemic Agents; Liver; Male; NAD; Rats; Rats, Sprague-Dawley; Thioridazine | 1998 |
Effects of peroxisome-proliferators on the TRP-NAD pathway.
Topics: Animals; Carboxy-Lyases; Cells, Cultured; Clofibrate; Female; Liver; Male; NAD; NADP; Niacin; Oxidation-Reduction; Pentosyltransferases; Peroxisome Proliferators; Peroxisomes; Phenothiazines; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Tryptophan | 1999 |
In vitro metabolism of the mammalian soluble epoxide hydrolase inhibitor, 1-cyclohexyl-3-dodecyl-urea.
Topics: Animals; Biotransformation; Chromatography, High Pressure Liquid; Clofibrate; Cyclohexanes; Cytochrome P-450 Enzyme System; Epoxide Hydrolases; Humans; Lauric Acids; Male; Mass Spectrometry; Microsomes, Liver; NAD; NADPH Dehydrogenase; Rats; Rats, Inbred F344; Solubility; Species Specificity; Time Factors; Urea | 2003 |
NAD levels in the rat primary cultured hepatocytes affected by peroxisome-proliferators.
Topics: Animals; Cells, Cultured; Clofibrate; Hepatocytes; NAD; Peroxisome Proliferators; Rats; Tryptophan | 2003 |
Differential effects of pyrazinamide and clofibrate on gene expression of rat hepatic alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, a key enzyme of the tryptophan-NAD pathway.
Topics: Analysis of Variance; Animals; Antitubercular Agents; Carboxy-Lyases; Clofibrate; Diet, Fat-Restricted; Diet, Protein-Restricted; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Hypolipidemic Agents; Kidney; Liver; Male; Models, Animal; NAD; Peroxisome Proliferators; Pyrazinamide; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Time Factors; Transcription, Genetic; Tryptophan; Weight Gain | 2006 |